BioSpace News Archive

A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market.

The T-cell therapy market is anticipated to rise at a stellar growth rate for the forecast period between 2020 and 2030.

Gyroscope Therapeutics Limited, a clinical-stage gene therapy company focused on diseases of the eye, announced the appointment of Jessica Stitt as Chief Financial Officer, effective immediately.

One single test determines the virus responsible for patient symptoms, guiding treatment decisions and rapid isolation strategy if required

Eurofins’s Clinical Enterprise, Inc. announces that it has received US Food and Drug Administration Emergency Use Authorization for a direct-to-consumer version of its EmpowerDX COVID-19 Home Collection Kit.

Evotec SE and Chinook Therapeutics, Inc. announced a strategic collaboration focused on the discovery and development of novel precision medicine therapies for patients with chronic kidney diseases.

The Barbara Ann Karmanos Cancer Institute, along with cancer centers and other organizations across the nation, recognizes March as Colorectal Cancer Awareness Month.

AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today announced the successful closing of an underwritten registered public offering of its shares of common stock, the details of which were released to the market on February 24, 2021

Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q1 2021. Highlights of Three Months Ended December 31, 2020 Sales and Product Offerings Gross profit margin was 48.1% for the three months ended December 31, 2020, compared to 57.1% for the same period in the previous year.

Sparta Group announces it has released its financial results for the three months ended December 31, 2020.